( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 4.84%58.230.0%$1733.38m
GILDGilead Sciences, Inc. -0.35%75.061.0%$1313.87m
REGNRegeneron Pharmaceuticals, Inc. 0.71%582.302.5%$968.15m
AMGNAmgen, Inc. -0.35%223.351.3%$644.09m
NVAXNovavax, Inc. 0.33%44.99102.0%$581.66m
VRTXVertex Pharmaceuticals, Inc. 0.21%277.951.9%$545.82m
BIIBBiogen, Inc. -0.08%300.251.6%$410.05m
ILMNIllumina, Inc. -1.97%365.683.5%$381.53m
SRNESorrento Therapeutics, Inc. -0.30%4.941.8%$297.10m
ALXNAlexion Pharmaceuticals, Inc. 0.87%115.422.0%$267.38m
SGENSeattle Genetics, Inc. 0.21%151.886.1%$255.06m
AAgilent Technologies, Inc. 0.75%87.341.6%$201.01m
BMRNBioMarin Pharmaceutical, Inc. -1.18%104.354.3%$177.65m
CODXCo-Diagnostics, Inc. -1.09%17.280.0%$169.00m
INCYIncyte Corp. -0.33%100.222.5%$156.98m

Company Profile

EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses in the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.